Liberum appointed Joint Corporate Broker to Malin Corporation Plc

Malin invests in and supports life sciences companies developing science and technology to deliver transformative outcomes for patients and create value for shareholders.

The company focuses on oncology, immunology and genetic diseases where they believe innovative life science and healthcare technologies will deliver transformative treatments for patients.

Malin raised €330m in 2015 through its IPO on the European Securities Market of Euronext Dublin (”ESM”).

Liberum has been appointed as the Company’s Joint Corporate Broker alongside Davy, Malin’s current ESM adviser and broker.

Liberum Team

Investment Banking - Bidhi Bhoma, Euan Brown, Laura Hamilton

Research - Alistair Campbell, Graham Doyle

Sales - Lisa Tugwell

Twitter: @LiberumToday

LinkedIn: Liberum